place Online
date_range June 10, 2026
⏰ Webinar Time: 14:00 – 15:30 (UTC+2, CEST)
🌐 View in other timezones
12:00 – 13:30 (UTC+0, UTC)
13:00 – 14:30 (UTC+1, BST)
07:00 – 08:30 (UTC-5, CDT)
05:00 – 06:30 (UTC-7, PDT)
21:00 – 22:30 (UTC+9, JST)
Reciprocal Effects of Drugs & the Microbiome
This webinar will provide clinicians, pharmacovigilance experts, public health professionals, and regulators with an understanding of how drugs affect the microbiome and how the microbiome influences drug metabolism, with a focus on regulatory and pharmacovigilance implications.
About the event
- mic 4 Speakers
Growing research on the human microbiome – the intricate and dynamic community of microorganisms living in and on our bodies – is reshaping understanding of health, disease, and medicines. Advances in metagenomics, metabolomics and systems biology show that the microbiome influences disease risk, drug metabolism, treatment response, and toxicity. Many medicines – not only antibiotics, but also drugs such as proton pump inhibitors, selective serotonin reuptake inhibitors, antipsychotics, opioids and statins can significantly alter microbial communities, while microbes themselves affect pharmacokinetics and pharmacodynamics. Despite these implications for treatment outcomes, antimicrobial resistance, pharmacovigilance, and regulation, microbiome interactions are not yet systematically considered in drug development or safety monitoring. Knowledge gaps remain across healthcare, regulation, and public understanding, creating challenges for clinicians, regulators, and patients. CIOMS proposes a webinar to provide an overview of current evidence, explore regulatory implications, and identify priorities for future guidance on drug–microbiome interactions.
Speakers and Panelists
-
Lembit Rägo
Secretary-General, CIOMS, Switzerland
-
Elin Org
Professor of Microbiomics; Head of the Estonian Genome Centre, Vice Director of University of Tartu Institute of Genomics, University of Tartu, Estonia
-
Lisa Maier
Professor for Microbiome-Host Interactions, University of Tübingen, Germany
-
Michael Zimmermann
Group Leader, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany
-
Oliver Aasmets
Research Fellow, University of Tartu, Estonia
-
Kertu Liis Krigul
Research Fellow, University of Tartu, Estonia
Webinar programme
schedule All times shown in CEST (Central European Summer Time, UTC+2)
Opening and welcome
Lembit Rägo
Drug-induced changes in the microbiome – overview
Elin Org
Experimental insights into drug–microbe interactions
Lisa Maier
Microbial metabolism of drugs
Michael Zimmermann
Panel discussion
Lembit Rägo, Lisa Maier, Elin Org, Michael Zimmermann, Oliver Aasmets, Kertu Liis Krigul
Webinar registration information
Not-for-profit attendees
The CIOMS WG XIV webinar will be free of charge for not-for-profit attendees such as academics, employees of international organisations, and regulators. As you complete the registration form below and select your sector, you will receive a coupon code that will exempt you from payment.
How to register for free: proceed to the payment page and enter the coupon code. The coupon will reduce the registration fee to 0 CHF. CIOMS reserves the right to cancel any free registration where an individual has misrepresented their situation. Alternatively, an invoice may be sent after the webinar.
For-profit attendees
The webinar will have an entrance fee of 99.00 CHF for for-profit attendees such as employees of pharmaceutical companies, contract research organisations (CROs), technology companies and consultants. As you complete the registration form below and select your sector, payment will become obligatory.
Places are limited and prior registration is necessary.
After completing the coupon flow or payment, you will see a confirmation of your registration, and within a couple of days, you will receive a confirmation email with a link to access the webinar.